Viewing nowActorin Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

MFDS item code 200705479 · Approved 2007.05.14 · Insurance code 662501390
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, but if blood sugar improvement is insufficient despite the use of other oral hypoglycemic agents, it should be co-administered with sulfonylureas, metformin, or insulin. Additionally, it is important for patients with type 2 diabetes to receive nutritional counseling and engage in weight loss and exercise, which not only aids in initial treatment but also helps maintain the effectiveness of drug therapy. Thus, this medication is effectively used for blood sugar control.
This medication is administered orally once daily, with or without food. 1. Monotherapy This medication may be started at 15 mg once daily as monotherapy in patients whose blood glucose is not adequately controlled by diet and exercise. If the initial dose does not provide an adequate effect, the dose may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, the initial dose is 15 mg once daily. - When used in combination with metformin, the initial dose is 15 mg once daily. - When used in combination with insulin, administer 15 mg once daily and adjust the insulin dose according to glycemic control. The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This medication is used to treat type 2 diabetes and helps control blood sugar by acting with insulin. This drug may place additional strain on the heart in some patients, potentially causing or worsening heart failure (congestive heart failure), so after starting treatment or increasing the dose, symptoms of heart failure such as weight change, shortness of breath, and swelling should be closely monitored. This medication should not be used in patients with heart failure, and if symptoms of heart failure occur, medical advice should be sought immediately to adjust the treatment. As this drug can cause fluid retention, which increases the risk of heart failure, patients with cardiovascular diseases like heart disease, hypertension, or myocardial infarction should take special caution. Patients with a history of or currently having bladder cancer should not be administered this drug, and if hematuria or urinary disorders occur during treatment, they should inform the physician immediately. Patients with impaired liver function or severe renal impairment should also preferably refrain from using this drug. Women who are pregnant or may become pregnant should not use this medication, and premenopausal women should use appropriate contraception as this drug can stimulate ovulation and raise the risk of pregnancy. During the use of this medication, regular monitoring of blood sugar and liver function tests should be conducted, and if symptoms such as weight gain, swelling, or shortness of breath occur, they should inform a physician immediately. Additionally, the risk of hypoglycemia may increase when this drug is used in conjunction with other diabetes medications or insulin, so when used together, patients should be well-informed about hypoglycemia symptoms and management methods. Elderly patients or those with impaired kidney or liver function should be monitored more closely during administration, and in case of overdose, immediate medical assistance should be sought for appropriate treatment. Finally, the safety and efficacy of this medication have not been confirmed in children, hence it is not used in that age group.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that excludes light and air, avoiding humid places and kept at a temperature between 15 to 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents degradation.
White to grayish-white round tablet
30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.